Extended Endocrine Therapy and Survival for Breast Cancer Subtypes in Premenopausal Patients - Top-Institutions - MDSpire

Extended Endocrine Therapy and Survival for Breast Cancer Subtypes in Premenopausal Patients

  • By

  • Carmine Valenza

  • Yue Zheng

  • Monica Milano

  • Pier Paolo Maria Berton Giachetti

  • Dario Trapani

  • Elisa Giordano

  • Lorenzo Guidi

  • Laura Boldrini

  • Grazia Castellano

  • Jalissa Katrini

  • Bianca Malagutti

  • Gabriele Antonarelli

  • Julian D. Etessami

  • Nadia Bianco

  • Fabio Conforti

  • Gregory J. Kirkner

  • Claudia Sangalli

  • Kate E. Dibble

  • Nicola Fusco

  • Marco Colleoni

  • Meredith M. Regan

  • Elisabetta Munzone

  • Giuseppe Curigliano

  • Ann H. Partridge

  • May 4, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Young Women’s Breast Cancer Study
    Young Women’s Breast Cancer Study

    N/A, N/A

    Key Differentiators

    • Oncology

  • #2

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Oncology

  • #3

    Early Breast Cancer Trialists’ Collaborative Group
    Early Breast Cancer Trialists’ Collaborative Group

    N/A, N/A

    Key Differentiators

    • Oncology

Original Source(s)

Extended Endocrine Therapy and Survival for Breast Cancer Subtypes in Premenopausal Patients

  • by Carmine Valenza, Yue Zheng, Monica Milano, Pier Paolo Maria Berton Giachetti, Dario Trapani, Elisa Giordano, Lorenzo Guidi, Laura Boldrini, Grazia Castellano, Jalissa Katrini, Bianca Malagutti, Gabriele Antonarelli, Julian D. Etessami, Nadia Bianco, Fabio Conforti, Gregory J. Kirkner, Claudia Sangalli, Kate E. Dibble, Nicola Fusco, Marco Colleoni, Meredith M. Regan, Elisabetta Munzone, Giuseppe Curigliano, Ann H. Partridge

  • May 4, 2026

Related Content

Breast, Cervical, and Colorectal Cancer Screening Rates in Women Aged 45 to 64 Years

Gastric metastasis from hormone receptor–positive breast cancer ten years after radical mastectomy: a case report and literature review

Clinician Perspectives on Implementing Breast Cancer–Related Lymphedema Prospective Screening